Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Company Information
About this company
Key people
Theresa Agnew
President, Chief Executive Officer
Alexander Kotsinas
Chief Financial Officer, Executive Vice President
Ludvig Milesson
Chief Operating Officer
Angelika Kjelldorff
Chief Human Resources Officer
Linda Hagglund
Chief Marketing Officer
Gianfranco Grompone
Chief Scientific Officer
Sebastian Heimfors
Chief Commercial Officer
Caroline Mofors
Chief Legal Officer
David E. R Dangoor
Independent Vice Chairman of the Board
Vanessa Rothschild
Director
Outi Armstrong
Independent Director
Benedicte Flambard
Independent Director
Barbro Friden
Independent Director
Click to see more
Key facts
- Shares in issue97.46m
- EPICBIOG B
- ISINSE0017769995
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capSEK 10.47bn
- Employees238
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.